腹腔镜(含机器人辅助)前列腺癌根治术安全共识

2020-07-20 中国医促会泌尿健康促进分会 现代泌尿外科杂志.2020.25(7):575-584.

随着人口老龄化的突显、人群健康意识的提高和饮食结构的改变及前列腺特异性抗原(PSA)筛查/检查的逐步普及,中国泌尿外科医师正在或即将面对越来越多的前列腺癌患者。对于早期/局限性前列腺癌,前列腺癌根治术

中文标题:

腹腔镜(含机器人辅助)前列腺癌根治术安全共识

发布日期:

2020-07-20

简要介绍:

随着人口老龄化的突显、人群健康意识的提高和饮食结构的改变及前列腺特异性抗原(PSA)筛查/检查的逐步普及,中国泌尿外科医师正在或即将面对越来越多的前列腺癌患者。对于早期/局限性前列腺癌,前列腺癌根治术是有效的治愈手段。通过系统化规范培训,掌握腹腔镜(机器人辅助)前列腺癌根治术是泌尿外科医师手术技术培养和训练的重要部分。但是,我们必须清楚地认识到,作为外科手术精细化的典范,高难度的前列腺癌根治术犹如达摩克利斯之剑,提醒实施该手术的外科医师时刻注意防范该术式的局限和风险,以最大限度保证手术质量和患者安全。

相关资料下载:
[AttachmentFileName(sort=1, fileName=腹腔镜_含机器人辅助_前列腺癌根治术安全共识_蔡林.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d186c1c0019a3371, title=腹腔镜(含机器人辅助)前列腺癌根治术安全共识, enTitle=, guiderFrom=现代泌尿外科杂志.2020.25(7):575-584., authorId=0, author=, summary=随着人口老龄化的突显、人群健康意识的提高和饮食结构的改变及前列腺特异性抗原(PSA)筛查/检查的逐步普及,中国泌尿外科医师正在或即将面对越来越多的前列腺癌患者。对于早期/局限性前列腺癌,前列腺癌根治术, cover=https://img.medsci.cn/2020731/1596200812697_2020535.jpg, journalId=0, articlesId=null, associationId=1623, associationName=中国医促会泌尿健康促进分会, associationIntro=, copyright=0, guiderPublishedTime=Mon Jul 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p style="color: #373737;">随着人口老龄化的突显、人群健康意识的提高和饮食结构的改变及前列腺特异性抗原(PSA)筛查/检查的逐步普及,中国泌尿外科医师正在或即将面对越来越多的前列腺癌患者。对于早期/局限性前列腺癌,前列腺癌根治术是有效的治愈手段。通过系统化规范培训,掌握腹腔镜(机器人辅助)前列腺癌根治术是泌尿外科医师手术技术培养和训练的重要部分。但是,我们必须清楚地认识到,作为外科手术精细化的典范,高难度的前列腺癌根治术犹如达摩克利斯之剑,提醒实施该手术的外科医师时刻注意防范该术式的局限和风险,以最大限度保证手术质量和患者安全。</p>, tagList=[TagDto(tagId=781, tagName=前列腺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=781, guiderKeyword=前列腺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3121, appHits=120, showAppHits=0, pcHits=522, showPcHits=3001, likes=1, shares=5, comments=11, approvalStatus=1, publishedTime=Fri Jul 31 21:09:09 CST 2020, publishedTimeString=2020-07-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri Jul 31 21:07:18 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 22:32:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=腹腔镜_含机器人辅助_前列腺癌根治术安全共识_蔡林.pdf)])
腹腔镜_含机器人辅助_前列腺癌根治术安全共识_蔡林.pdf
下载请点击:
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1011239, encodeId=04c8101123953, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27855555819, createdName=zzk889, createdTime=Wed Aug 25 09:20:42 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011238, encodeId=6ecb1011238f7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27855555819, createdName=zzk889, createdTime=Wed Aug 25 09:20:24 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011237, encodeId=e32f101123e32, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27855555819, createdName=zzk889, createdTime=Wed Aug 25 09:20:20 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968998, encodeId=c6bc9689981d, content=学校了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Thu May 27 20:43:58 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892837, encodeId=cfa989283ed1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKT6cbtvT3o7icibpicpHiamGPlBJiaToQoNdqibGHpfiaibg9Mx79wgicJ7lM43SzmXibeZI8oIEh2vZvnhUtw/132, createdBy=744b2171805, createdName=answer.col, createdTime=Sun Oct 18 14:22:50 CST 2020, time=2020-10-18, status=1, ipAttribution=)]
    2021-08-25 zzk889

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1011239, encodeId=04c8101123953, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27855555819, createdName=zzk889, createdTime=Wed Aug 25 09:20:42 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011238, encodeId=6ecb1011238f7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27855555819, createdName=zzk889, createdTime=Wed Aug 25 09:20:24 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011237, encodeId=e32f101123e32, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27855555819, createdName=zzk889, createdTime=Wed Aug 25 09:20:20 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968998, encodeId=c6bc9689981d, content=学校了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Thu May 27 20:43:58 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892837, encodeId=cfa989283ed1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKT6cbtvT3o7icibpicpHiamGPlBJiaToQoNdqibGHpfiaibg9Mx79wgicJ7lM43SzmXibeZI8oIEh2vZvnhUtw/132, createdBy=744b2171805, createdName=answer.col, createdTime=Sun Oct 18 14:22:50 CST 2020, time=2020-10-18, status=1, ipAttribution=)]
    2021-08-25 zzk889

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1011239, encodeId=04c8101123953, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27855555819, createdName=zzk889, createdTime=Wed Aug 25 09:20:42 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011238, encodeId=6ecb1011238f7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27855555819, createdName=zzk889, createdTime=Wed Aug 25 09:20:24 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011237, encodeId=e32f101123e32, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27855555819, createdName=zzk889, createdTime=Wed Aug 25 09:20:20 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968998, encodeId=c6bc9689981d, content=学校了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Thu May 27 20:43:58 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892837, encodeId=cfa989283ed1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKT6cbtvT3o7icibpicpHiamGPlBJiaToQoNdqibGHpfiaibg9Mx79wgicJ7lM43SzmXibeZI8oIEh2vZvnhUtw/132, createdBy=744b2171805, createdName=answer.col, createdTime=Sun Oct 18 14:22:50 CST 2020, time=2020-10-18, status=1, ipAttribution=)]
    2021-08-25 zzk889

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1011239, encodeId=04c8101123953, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27855555819, createdName=zzk889, createdTime=Wed Aug 25 09:20:42 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011238, encodeId=6ecb1011238f7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27855555819, createdName=zzk889, createdTime=Wed Aug 25 09:20:24 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011237, encodeId=e32f101123e32, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27855555819, createdName=zzk889, createdTime=Wed Aug 25 09:20:20 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968998, encodeId=c6bc9689981d, content=学校了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Thu May 27 20:43:58 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892837, encodeId=cfa989283ed1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKT6cbtvT3o7icibpicpHiamGPlBJiaToQoNdqibGHpfiaibg9Mx79wgicJ7lM43SzmXibeZI8oIEh2vZvnhUtw/132, createdBy=744b2171805, createdName=answer.col, createdTime=Sun Oct 18 14:22:50 CST 2020, time=2020-10-18, status=1, ipAttribution=)]
    2021-05-27 14775a26m11暂无昵称

    学校了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1011239, encodeId=04c8101123953, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27855555819, createdName=zzk889, createdTime=Wed Aug 25 09:20:42 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011238, encodeId=6ecb1011238f7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27855555819, createdName=zzk889, createdTime=Wed Aug 25 09:20:24 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011237, encodeId=e32f101123e32, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27855555819, createdName=zzk889, createdTime=Wed Aug 25 09:20:20 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968998, encodeId=c6bc9689981d, content=学校了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Thu May 27 20:43:58 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892837, encodeId=cfa989283ed1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKT6cbtvT3o7icibpicpHiamGPlBJiaToQoNdqibGHpfiaibg9Mx79wgicJ7lM43SzmXibeZI8oIEh2vZvnhUtw/132, createdBy=744b2171805, createdName=answer.col, createdTime=Sun Oct 18 14:22:50 CST 2020, time=2020-10-18, status=1, ipAttribution=)]
    2020-10-18 answer.col

    学习了

    0

拓展阅读

2010 ACS 前列腺癌早期筛查指南

美国癌症学会(ACS,American Cancer Society) · 2010-03-01

2010CCO 前列腺癌根治性前列腺切除术病理T3或边缘阳性的辅助放射治疗

加拿大安大略癌症治疗中心(CCO,Cancer Care Ontario) · 2010-04-15

ESMO临床实践指南:前列腺癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-05-01

2008 前列腺癌骨转移临床诊疗专家共识(2008版)

恶性肿瘤骨转移及骨相关疾病临床诊疗专家组 · 2010-05-01

2011EAU前列腺癌诊疗指南

欧洲泌尿外科学会(EAU,European Association of Urology) · 2011-01-01

前列腺癌诊断标准

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2011-07-01